|
Volumn 350, Issue 10, 2004, Pages 1049-1053
|
Nonsurgical Treatment of Laryngeal Cancer [1] (multiple letters)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CISPLATIN;
ANTINEOPLASTIC AGENT;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
HUMAN;
LARYNGECTOMY;
LARYNX CANCER;
LETTER;
PRIORITY JOURNAL;
TREATMENT INDICATION;
CANCER STAGING;
LARYNX TUMOR;
LASER SURGERY;
LYMPHADENECTOMY;
MULTIMODALITY CANCER THERAPY;
NOTE;
SURVIVAL RATE;
STATISTICAL ANALYSIS;
SURVIVAL;
EPIDEMIOLOGY;
RADIATION DOSE FRACTIONATION;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COMBINED MODALITY THERAPY;
HUMANS;
LARYNGEAL NEOPLASMS;
LARYNGECTOMY;
LASER SURGERY;
LYMPH NODE EXCISION;
NEOPLASM STAGING;
SURVIVAL RATE;
DATA INTERPRETATION, STATISTICAL;
SURVIVAL ANALYSIS;
BIAS (EPIDEMIOLOGY);
CISPLATIN;
DOSE FRACTIONATION;
|
EID: 12144287233
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200403043501017 Document Type: Letter |
Times cited : (11)
|
References (0)
|